Blum, David, 1971-...., directeur de recherche Inserm
David Blum researcher
Blum, David (Of Université de Lille)
Blum, David
VIAF ID: 17150262698105720384 (Personal)
Permalink: http://viaf.org/viaf/17150262698105720384
Preferred Forms
4xx's: Alternate Name Forms (3)
5xx's: Related Names (3)
- 510 2 _
‡a
Institut National de la Santé et de la Recherche Médicale
‡4
affi
‡4
https://d-nb.info/standards/elementset/gnd#affiliation
‡e
Affiliation
- 510 2 _
‡a
Jean-Pierre Aubert Research Centre
‡4
affi
‡4
https://d-nb.info/standards/elementset/gnd#affiliation
‡e
Affiliation
- 551 _ _
‡a
Lille
‡4
ortw
‡4
https://d-nb.info/standards/elementset/gnd#placeOfActivity
Works
Title | Sources |
---|---|
Adenosine 2A receptor signalling as a key mechanism of stabilization of newly formed GABAergic synapses. |
![]() |
Behavioral and striatal alterations with aging in two mouse models of autism spectrum disorders. |
![]() |
The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function. |
![]() |
Caffeine Consumption During Pregnancy Accelerates the Development of Cognitive Deficits in Offspring in a Model of Tauopathy |
![]() |
Caractérisation et modulation du microbiote intestinal dans le contexte de la maladie d'Alzheimer : vers une nouvelle piste thérapeutique |
![]() |
Caractérisation et régulation de la mort de cellules catécholaminergiques induite in vitro par une neurotoxine, la 6-hydroxydopamine |
![]() |
The Chemokine MIP-1α/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory |
![]() |
Cleanup at the right time : a common mechanism underlies the molecular clock of microglia and neuronal activity in metabolic and memory control |
![]() |
Clinical potential of minocycline for neurodegenerative disorders |
![]() |
Consensus brain-derived protein, extraction protocol for the study of human and murine brain proteome using both 2D-DIGE and mini 2DE immunoblotting. |
![]() |
Conséquences de l'invalidation génétique et pharmacologique des récepteurs adénosinergiques A2A dans un modèle de pathologie Tau : Relation avec les aspects neuro-inflammatoires |
![]() |
Control of absence epilepsy by D3 dopaminergic receptor and dopamine transporter. |
![]() |
Contrôle des activités synchrones oscillatoires pathologiques par le récepteur dopaminergique D3 et le transporteur de la dopamine. |
![]() |
Death of cortical and striatal neurons induced by mitochondrial defect involves differential molecular mechanisms |
![]() |
Développement d'un nouveau modèle murin par transfert de gène pour étudier la propagation de la tauopathie : influence de l'agrégation de la protéine tau et de l'activation microgliale |
![]() |
Early Tau pathology involving the septo-hippocampal pathway in a Tau transgenic model: relevance to Alzheimer's disease. |
![]() |
Les effets du stress chronique et des glucocorticoïdes sur la plasticité cérébrale et la pathologie Tau. |
![]() |
Étude de la composante neuroinflammatoire dans les DFT/SLA |
![]() |
Etude des interactions entre la microglie et les synapses dépendantes de l'activité : évaluation de la voie de signalisation de l'adénosine |
![]() |
Étude du rôle neuronal des isoformes du facteur de risque génétique BIN1 dans la maladie d'Alzheimer |
![]() |
Etude in vivo des relations entre la pathologie Tau et le système neurotrophique BDNF/TRKB |
![]() |
Évaluation de l'efficacité neuroprotectrice et neuro-restauratrice du lysat de plaquettes humaines chauffe dans des modèles de lésions traumatiques cérébrales. |
![]() |
Evaluation of an In Situ Polymerizing Hydrogel Scaffold as a Brain Delivery System for Parkinson's Disease therapeutics |
![]() |
Evaluation of the calcium channel TRPA1 as a potential therapeutic target in the pathogenesis of Alzheimer's disease. |
![]() |
Examining the neuroprotective and neuro-restorative efficacy of heat-treated human platelet pellet lysate in traumatic brain injury models |
![]() |
Exploration du rôle de la protéine Tau dans la régulation de l'homéostasie du glucose. |
![]() |
From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease? |
![]() |
A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease. |
![]() |
Heat-treated human platelet pellet lysate modulates microglia activation, favors wound healing and promotes neuronal differentiation in vitro |
![]() |
Human platelet concentrates: a source of solvent/detergent-treated highly enriched brain-derived neurotrophic factor. |
![]() |
Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism. |
![]() |
Identification and charaterization of new molecular determinants of cisplatin resistance and nephrotoxicity in lung adenocarcinoma. |
![]() |
Impaired Glucose Homeostasis in a Tau Knock-In Mouse Model |
![]() |
Implication de nouvelles cibles microgliales, Cst7 et Clec7a/Dectin-1, dans le développement et la progression de la maladie d'Alzheimer |
![]() |
Implication of neuronal versus glial purinergic receptor P2X4 in chronic neuropathic and inflammatory pain. |
![]() |
Increased Alix (apoptosis-linked gene-2 interacting protein X) immunoreactivity in the degenerating striatum of rats chronically treated by 3-nitropropionic acid. |
![]() |
Involvement of neutrophils in the pathophysiology of Alzheimer’s disease and tauopathies. |
![]() |
Involvment of new microglial genes in Alzheimer's disease development, focus on Cst7 and Clec7a/Dectin-1. |
![]() |
IRM multiparamétrique pour la recherche de biomarqueurs précoces des maladies par expansion de polyglutamine |
![]() |
Lack of minocycline efficiency in genetic models of Huntington's disease |
![]() |
Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study |
![]() |
Metabolism and Tau pathology in Alzheime's disease : a reciprocal relationship ?. |
![]() ![]() |
Métabolisme et pathologie Tau dans la maladie d'Alzheimer : une relation réciproque ? |
![]() |
Minocycline-induced activation of tetracycline-responsive promoter. |
![]() |
Molecular mechanism of ADCY5-related movement disorder : study of a new genetic mouse model and identification of therapeutic targets |
![]() |
MRNA Levels of ACh-Related Enzymes in the Hippocampus of THY-Tau22 Mouse: A Model of Human Tauopathy with No Signs of Motor Disturbance. |
![]() |
Multiparametric MRI for the Research of Early Biomarkers in Polyglutamine Diseases. |
![]() |
Mutual relationship between Tau and central insulin signalling: consequences for AD and Tauopathies ? |
![]() |
Mycoplasmas as gene therapy vectors? |
![]() |
Neuroprotective gene therapy for Parkinson's disease. |
![]() |
Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-β1-42 oligomers are revealed in vivo by using a novel animal model. |
![]() |
New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease |
![]() |
NLRP3 inflammasome activation drives tau pathology |
![]() |
NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model. |
![]() |
Novel Alzheimer risk genes determine the microglia response to amyloid-β but not to TAU pathology |
![]() |
Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy. |
![]() |
Nuclear factor-kappa B activation in permanent intraluminal focal cerebral ischemia in the rat |
![]() |
Overexpression of mouse IsK protein fused to green fluorescent protein induces apoptosis of human astroglioma cells. |
![]() |
p53 and Bax activation in 6-hydroxydopamine-induced apoptosis in PC12 cells. |
![]() |
Premature ovarian aging in mice deficient for Gpr3. |
![]() |
Progressive age-related cognitive decline in tau mice. |
![]() |
Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator |
![]() |
Rescue of impaired late-phase long-term depression in a tau transgenic mouse model. |
![]() |
RLU and studies using the luciferase reporter gene. |
![]() |
Rôle central des glucocorticoïdes et de leurs récepteurs dans l'étiologie de la Maladie d'Alzheimer |
![]() |
The Role of Adenosine Tone and Adenosine Receptors in Huntington's Disease |
![]() ![]() ![]() |
Role of the Tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms |
![]() |
Solvent-detergent filtered |
![]() |
A ß-Secretase Modulator Decreases Tau Pathology and Preserves Short-Term Memory in a Mouse Model of Neurofibrillary Degeneration |
![]() |
Stabilization of hippocampal glutamatergic synapses by adenosinergic signaling involving neuroglial interactions. |
![]() |
Study of potential involvement of striatal markers in Huntington's disease. |
![]() |
Study of the molecular mechanisms involved in the cerebral infiltration of lymphocytes T in the Parkinson's disease. |
![]() |
Study of the neuroinflammatory component in FTD/ALS. |
![]() |
Tacrolimus-induced nephrotoxicity in mice is associated with microRNA deregulation. |
![]() |
Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies? |
![]() |
Tau- but not Aß -pathology enhances NMDAR-dependent depotentiation in AD-mouse models |
![]() |
Tau deletion promotes brain insulin resistance |
![]() |
Tau, Diabetes and Insulin |
![]() |
Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarker |
![]() |
Tau phosphorylation and sevoflurane anesthesia: an association to postoperative cognitive impairment. |
![]() |
Unlike MPP+, apoptosis induced by 6-OHDA in PC12 cells is independent of mitochondrial inhibition |
![]() |
Worsening of Huntington disease phenotype in CB1 receptor knockout mice |
![]() |